Fetal Heart Rate Pattern After Spinal Anesthesia for Scheduled Uncomplicated Cesarean Section

March 16, 2023 updated by: Taichung Veterans General Hospital

Fetal Heart Rate Pattern Before, During, and After Spinal Anesthesia for Scheduled Uncomplicated Cesarean Section

Spinal anesthesia may cause sympathetic blockade which decrease peripheral vascular resistance and bradycardia and then hypotension. Maternal hypotension could cause immediate fetus heart beat (FHB) deceleration and postpartum acidosis. Both intravenous hydration or vasopressor during hypotension could prevent maternal hypotension efficiently. Although there were many articles discussion about maternal hypotension and fetal heart rate variation during epidural labor analgesia, the studies about FHB variation during spinal anesthesia is not much. In one literature in 1960, if maternal blood pressure below 60-80 mmHg, FHB deceleration could happen in 5 minutes. In modern medical management, FHB change during and after spinal anesthesia is an interesting topic. The most relevant study was published by NTUH in 2015, which transformed EKG signal to possible FHB change.

The parturient will have FHB recording for 20 minutes in the day before operation. On the operation day, after proper position by the anesthetic staff (lateral position or sitting position), spinal anesthesia will performed by obstetric anesthesiologist and the lying down for supine position. Before the baby was delivered by cesarean section no FHB will be monitored. The aim of the study is continuous FHB monitor and analysis after spinal anesthesia for 5-10 minutes to improve fetal physiology knowledge and providing basic information for future study.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taichung, Taiwan
        • Recruiting
        • Taichung Veterans General Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Pregnant women for gestational age above 36 weeks

Description

Inclusion Criteria:

  1. Age above 20 years
  2. Singleton
  3. Gestational age above 36 weeks
  4. Scheduled Cesarean section at VGHTC
  5. Eligible for spinal anesthesia
  6. Inform consent

Exclusion Criteria:

  1. ASA > 3
  2. Prenatal examination reveal suspect neonatal congenital heart disease, heart failure, arrythymia or hydrops fetalis which could affect fetal heart beat
  3. Regular uterine contraction, premature rupture of membrane or vaginal bleeding before scheduled C/S on prenatal clinic
  4. Anticipate vaginal delivery initially but shift to C/S for prolong labor, FHB deceleration or other reason
  5. Patients cannot make decision for language barrier, education condition or phsycological disease
  6. Register in other study already

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Before spinal anesthesia
Before spinal anesthesia with heavy bupivacaine 12.5 mg is administrated.
Spinal anesthesia
After spinal anesthesia
After spinal anesthesia with heavy bupivacaine 12.5 mg is administrated.
Spinal anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fetal heart rate variability
Time Frame: 5 minutes after spinal anesthesia
Fetal heart rate deceleration (normal > 100 beats per minute)
5 minutes after spinal anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal outcome
Time Frame: 1 minute and 5 minutes after delivery
APGAR score_1 minute, APGAR score_5 minute ( APGAR score: 0-10 points)
1 minute and 5 minutes after delivery
Neonatal intensive care rate
Time Frame: baseline (admission)
NICU admission rate
baseline (admission)
Umbilical vein analysis
Time Frame: within 5 minutes after delivery
Umbilical vein blood gas analysis, including pH, O2, CO2, HgB, electrolyte
within 5 minutes after delivery
Maternal pain score
Time Frame: 0, 8, 24 hours after surgery
Visual analog scale ( VAS score 0-10)
0, 8, 24 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2022

Primary Completion (Anticipated)

October 13, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

December 2, 2022

First Submitted That Met QC Criteria

March 16, 2023

First Posted (Actual)

March 20, 2023

Study Record Updates

Last Update Posted (Actual)

March 20, 2023

Last Update Submitted That Met QC Criteria

March 16, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Continuous Fetal Heart Beat Monitor and Analysis After Spinal Anesthesia

Clinical Trials on Spinal anesthesia with heavy bupivacaine

Subscribe